Search Within

Roisin Eilish O'Cearbhaill

Formats
  1. Meeting Abstract (127)
  2. Journal Article (124)
  3. Review (9)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (272)
  2. GDMT, Medicine (272)
  3. Gynecologic Medicine Service (272)
  4. Gynecology Disease Management Team (272)
  5. Hematologic Malignancies, Division of (272)
  6. Solid Tumor Oncology Division (272)

More Groups

People
  1. Carol Aghajanian (99)
  2. Alexia Iasonos (75)
  3. Qin Zhou (68)
  4. Rachel Grisham (68)
  5. Dennis Chi (67)
  6. William Tew (66)

More People

Years
  1. 2025 (14)
  2. 2024 (30)
  3. 2023 (43)
  4. 2022 (31)
  5. 2021 (25)
  6. 2020 (41)

More Years

Publications
  1. Gynecologic Oncology (91)
  2. Journal of Clinical Oncology (45)
  3. International Journal of Gynecological Cancer (39)
  4. Annals of Oncology (13)
  5. Gynecologic Oncology Reports (11)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (98)
  2. American Society of Clinical Oncology (48)
  3. Lippincott Williams & Wilkins (40)
  4. American Association for Cancer Research (13)
  5. Oxford University Press (13)
  6. Elsevier B.V. (11)

More Publishers

Results (272)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: Results of a phase II study (MOONSTONE/GOG-3032)
    Journal Article

    Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S.; Duska, L. R.; Dalton, H.; Holloway, R. W.; Huang, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Use of romiplostim in chemotherapy-induced thrombocytopenia in gynecologic and breast cancers
    Meeting Abstract

    Moufarrij, S.; O'Cearbhaill, R.; Zhou, Q.; Iasonos, A.; Mantha, S.; Wilkins, C.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • PRIMA/ENGOT-OV26/GOG-3012 study: Updated Long-term progression-free survival and safety
    Meeting Abstract

    Heitz, F.; González-Martín, A.; Pothuri, B.; Vergote, I.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Freyer, G.; Backes, F.; more...
    Anticancer Research (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus chemotherapy in advanced endometrial cancer
    Journal Article

    Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • First-in-human phase 1/2 study of ubamatamab, a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
    Meeting Abstract

    Moore, K. N.; Bouberhan, S.; Hamilton, E. P.; Liu, J. F.; O'Cearbhaill, R. E.; O'Malley, D. M.; Papadamitriou, K.; Schröder, D.; Van N., Els; Yoo, S. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 trial of gavocabtagene autoleucel (gavo-cel, TC-210) in patients (pts) with treatment refractory mesothelioma and other mesothelin-expressing solid tumors
    Meeting Abstract

    Hassan, R.; Butler, M. O.; Oh, D. Y.; O'Cearbhaill, R. E.; MacMullen, L.; Jeter, E.; Guha, U.; Muzithras, V. P.; Zikaras, K.; Johnson, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: Phase 1/2 trial interim results
    Journal Article

    Hassan, R.; Butler, M.; O’Cearbhaill, R. E.; Oh, D. Y.; Johnson, M.; Zikaras, K.; Smalley, M.; Ross, M.; Tanyi, J. L.; Ghafoor, A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Progression-free survival and safety at 3.5 years of follow-up: Results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
    Journal Article

    González-Martín, A.; Pothuri, B.; Vergote, I.; Graybill, W.; Lorusso, D.; McCormick, C. C.; Freyer, G.; Backes, F.; Heitz, F.; Redondo, A.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save